Literature DB >> 8047724

Massive pericardial effusion in sarcoidosis.

R H Israel1, R H Poe.   

Abstract

Massive pericardial effusion in sarcoidosis is rare. We summarize the features of a recent patient along with a review of 9 previously reported cases. All but 1 patient with massive pericardial effusion were female and all had massive cardiomegaly on their chest roentgenogram with 7 of the 10 also showing features suggestive of sarcoidosis (bilateral hilar adenopathy with or without interstitial infiltrates). Nine of the 10 patients required a drainage procedure (pericardiectomy or pericardiocentesis). Pericardial histology revealed noncaseating granulomas in 6 of 7 patients. Two of the patients expired within the first week of hospitalization with evidence of myocardial involvement. The remainder of the patients have had clinical stability most responding to steroids, yet recurrences were seen in 3 patients and 1 patient required cyclophosphamide for control.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047724     DOI: 10.1159/000196333

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Cardiac sarcoidosis: diagnosis and management.

Authors:  Michelle Bussinguer; Alfred Danielian; Om P Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 2.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

3.  Rare manifestations of sarcoidosis in modern era of new diagnostic tools.

Authors:  Surendra K Sharma; Manish Soneja; Abhishek Sharma; Mehar C Sharma; Smriti Hari
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

4.  Recurrent pleural and pericardial effusions due to sarcoidosis.

Authors:  Sankar D Navaneethan; Sundar Venkatesh; Rakesh Shrivastava; Jagat Mehta; Robert Israel
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.